A key component of the MAP kinase signal transduction pathway, Map2k1, was down-regulated in the IR and HLU + IR groups at 7 days but up-regulated at 1 month; MAPK signaling has been shown to be involved in AMD pathogenesis29. The gene discussed is MAP2K1; the disease is age-related macular degeneration.